AstraZeneca has signed a $555 million deal with a San Francisco-based biotech business Algen Biotechnologies, The Financial Times reported on Monday. The agreement with Algen gives AstraZeneca ...

The agreement with Algen Biotechnologies gives AstraZeneca exclusive rights to develop and commercialise therapies from the ...

A gene-editing therapy led to durable changes in serum transthyretin levels among people with hereditary transthyretin ...

Pigs Modified With CRISPR Gene-Editing Technology Could Be Available For Human Consumption Very Soon TwistedSifter Battery ...

Treatment introduces an expansion of the scope of gene therapies that might lead to similar treatments for neurodegenerative ...

The company is gene editing crops to make our food supply more resilient to climate change.

A gene-editing tool that can turn genes on and off like a light switch has been developed. Turning a gene on means activating the production of ...

Researchers at Harvard Medical School developed a tool that could use artificial intelligence to accelerate drug discovery ...

Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell ...

The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...

In a development that could help protect one of the world's most beloved agricultural commodities, a research team at Penn ...

Founded in 2020 by Chilean biochemist Bernardo Pollak, Meristem is using precise gene editing techniques to develop local ...